The Moving Average Convergence Divergence (MACD) for BAK turned positive on October 05, 2026. Looking at past instances where BAK's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BAK's RSI Indicator exited the oversold zone, 40 of 50 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on BAK as a result. In 56 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
Following a +8.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAK advanced for three days, in 185 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 48 cases where BAK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
BAK moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BAK's P/B Ratio (142.857) is very high in comparison to the industry average of (10.717). P/E Ratio (7.446) is within average values for comparable stocks, (27.649). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (3.769). BAK's Dividend Yield (0.311) is considerably higher than the industry average of (0.044). P/S Ratio (0.051) is also within normal values, averaging (0.578).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. BAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
LYB saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned positive. In 72 of the 102 cases, the stock moved higher in the following days. The odds of a move higher are at 71%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LYB's RSI Oscillator exited the oversold zone, 16 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
The Moving Average Convergence Divergence (MACD) for LYB just turned positive on October 08, 2026. Looking at past instances where LYB's MACD turned positive, the stock continued to rise in 30 of 50 cases over the following month. The odds of a continued upward trend are 60%.
LYB moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where LYB advanced for three days, in 183 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for LYB crossed bearishly below the 50-day moving average on September 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
LYB broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for LYB entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.764) is normal, around the industry mean (6.363). P/E Ratio (98.766) is within average values for comparable stocks, (209.940). Projected Growth (PEG Ratio) (1.526) is also within normal values, averaging (1.548). LYB's Dividend Yield (0.059) is considerably higher than the industry average of (0.013). P/S Ratio (0.670) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. LYB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 99 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
BAK | LYB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 34 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 30 Undervalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 99 | |
SMR RATING 1..100 | 100 | 92 | |
PRICE GROWTH RATING 1..100 | 83 | 45 | |
P/E GROWTH RATING 1..100 | 6 | 2 | |
SEASONALITY SCORE 1..100 | 50 | 19 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LYB's Valuation (11) in the Chemicals Specialty industry is in the same range as BAK (30). This means that LYB’s stock grew similarly to BAK’s over the last 12 months.
LYB's Profit vs Risk Rating (99) in the Chemicals Specialty industry is in the same range as BAK (100). This means that LYB’s stock grew similarly to BAK’s over the last 12 months.
LYB's SMR Rating (92) in the Chemicals Specialty industry is in the same range as BAK (100). This means that LYB’s stock grew similarly to BAK’s over the last 12 months.
LYB's Price Growth Rating (45) in the Chemicals Specialty industry is somewhat better than the same rating for BAK (83). This means that LYB’s stock grew somewhat faster than BAK’s over the last 12 months.
LYB's P/E Growth Rating (2) in the Chemicals Specialty industry is in the same range as BAK (6). This means that LYB’s stock grew similarly to BAK’s over the last 12 months.
| BAK | LYB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 80% | 1 day ago 64% |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 66% |
| Momentum ODDS (%) | 1 day ago 72% | 1 day ago 71% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 60% |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 61% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 57% |
| Advances ODDS (%) | 10 days ago 74% | 1 day ago 60% |
| Declines ODDS (%) | 1 day ago 86% | 6 days ago 58% |
| BollingerBands ODDS (%) | N/A | 1 day ago 65% |
| Aroon ODDS (%) | N/A | 1 day ago 56% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAK’s FA Score shows that 2 FA rating(s) are green while LYB’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAK’s TA Score shows that 4 TA indicator(s) are bullish while LYB’s TA Score has 5 bullish TA indicator(s).
BAK (@Chemicals: Major Diversified) experienced а -8.79% price change this week, while LYB (@Chemicals: Specialty) price change was +6.63% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Major Diversified industry was +2.48%. For the same industry, the average monthly price growth was -5.62%, and the average quarterly price growth was -21.87%.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -2.62%. For the same industry, the average monthly price growth was -3.89%, and the average quarterly price growth was -5.01%.
BAK is expected to report earnings on Nov 12, 2026.
LYB is expected to report earnings on Oct 30, 2026.
The major diversified chemicals industry includes companies that produce a wide range of chemicals and industrial gases. The products are often used as raw materials in the manufacturing of various types of goods, including plastics, paints, carpets, and fixtures to name a few. Major companies making diversified chemicals include DuPont de Nemours Inc., Celanese Corporation, Celanese Corporation and Westlake Chemical Corporation.
@Chemicals: Specialty (-2.62% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
A.I.dvisor indicates that over the last year, LYB has been closely correlated with DOW. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYB jumps, then DOW could also see price increases.